Veradigm - 26 Year Stock Price History | MDRX
Historical daily share price chart and data for Veradigm since 1999 adjusted for splits and dividends. The latest closing stock price for Veradigm as of June 11, 2025 is 4.40.
- The all-time high Veradigm stock closing price was 45.70 on March 09, 2000.
- The Veradigm 52-week high stock price is 11.80, which is 168.2% above the current share price.
- The Veradigm 52-week low stock price is 3.80, which is 13.6% below the current share price.
- The average Veradigm stock price for the last 52 weeks is 7.77.
| Veradigm Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 5.3189 | 9.1000 | 9.7500 | 3.9000 | 4.4000 | -54.87% |
| 2024 | 9.1198 | 10.7500 | 11.2500 | 5.9900 | 9.7500 | -7.05% |
| 2023 | 13.4220 | 17.2200 | 19.5900 | 9.5100 | 10.4900 | -40.53% |
| 2022 | 17.9518 | 18.6100 | 23.0900 | 13.8500 | 17.6400 | -4.39% |
| 2021 | 16.2178 | 14.3300 | 18.7800 | 13.1900 | 18.4500 | 27.77% |
| 2020 | 8.7316 | 9.6900 | 14.6100 | 5.0200 | 14.4400 | 47.05% |
| 2019 | 10.4970 | 9.7800 | 12.2100 | 8.7600 | 9.8200 | 1.87% |
| 2018 | 12.8046 | 14.9800 | 16.0300 | 8.6400 | 9.6400 | -33.75% |
| 2017 | 12.7107 | 10.9300 | 14.9100 | 10.5300 | 14.5500 | 42.51% |
| 2016 | 12.7938 | 14.4300 | 14.6500 | 10.0000 | 10.2100 | -33.62% |
| 2015 | 13.4710 | 12.8500 | 15.5300 | 11.6100 | 15.3800 | 20.44% |
| 2014 | 15.1701 | 15.3900 | 19.4300 | 11.2300 | 12.7700 | -17.40% |
| 2013 | 13.7477 | 9.4100 | 16.2600 | 9.3700 | 15.4600 | 64.12% |
| 2012 | 13.4261 | 18.3100 | 21.4700 | 8.9900 | 9.4200 | -50.26% |
| 2011 | 19.4391 | 19.5700 | 22.7100 | 14.4900 | 18.9400 | -1.71% |
| 2010 | 18.4029 | 20.3800 | 22.4100 | 15.7700 | 19.2700 | -4.75% |
| 2009 | 14.6468 | 9.9700 | 22.1300 | 7.8500 | 20.2300 | 103.93% |
| 2008 | 6.9148 | 9.9949 | 11.1000 | 4.6547 | 9.9200 | -3.87% |
| 2007 | 13.2071 | 14.2511 | 16.4669 | 9.1022 | 10.3191 | -28.05% |
| 2006 | 10.7473 | 7.3594 | 15.3510 | 7.3594 | 14.3415 | 101.42% |
| 2005 | 7.8874 | 5.4837 | 9.9524 | 4.9735 | 7.1203 | 25.59% |
| 2004 | 4.4460 | 2.9384 | 5.8716 | 2.7950 | 5.6696 | 100.57% |
| 2003 | 1.9295 | 1.1956 | 3.1775 | 1.0308 | 2.8268 | 122.58% |
| 2002 | 1.9543 | 1.7216 | 3.5282 | 1.0096 | 1.2700 | -26.23% |
| 2001 | 2.7958 | 3.9354 | 6.1937 | 1.1690 | 1.7216 | -65.32% |
| 2000 | 16.4471 | 27.6308 | 45.6971 | 3.1882 | 4.9649 | -78.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.476B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.227B | 59.07 |
| Hims & Hers Health (HIMS) | United States | $12.367B | 128.49 |
| Tempus AI (TEM) | United States | $12.011B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.742B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.033B | 63.01 |
| Hinge Health (HNGE) | United States | $2.855B | 0.00 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Schrodinger (SDGR) | United States | $1.917B | 0.00 |
| Enovis (ENOV) | United States | $1.916B | 10.69 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.522B | 0.00 |
| Omnicell (OMCL) | United States | $1.463B | 25.82 |
| Azenta (AZTA) | United States | $1.393B | 64.72 |
| 10x Genomics (TXG) | United States | $1.311B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.663B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.645B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.33 |
| Outset Medical (OM) | United States | $0.366B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.288B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 3.60 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |